Elevated TET3 expression is correlated with improved 5-year survival (42%), and the tumor-suppressive role of TET3 is mechanistically linked to the 5mC hydroxylation-mediated maintenance of open chromatin states at neurodifferentiation-associated genes (e.g., PHOX2B). This evidence concerns the gene TET3 and neoplasm.